Sign in to continue:

Tuesday, March 10th, 2026

Phillips 66 8-K SEC Filing Summary March 6, 2026 – Company Information, Stock Details, and Compliance Status

Phillips 66 Announces Board Changes: Appointment of Two New Directors and Board Rebalancing

Key Points:

  • Phillips 66 Board of Directors has appointed two new directors, Dr. Meyers and Mr. Ungerleider, effective March 6, 2026.
  • These appointments are not the result of any arrangement or understanding with existing directors, management, or any third party.
  • Neither Dr. Meyers nor Mr. Ungerleider has any direct or indirect material interest in any transaction requiring disclosure under SEC regulations.
  • Both new directors will receive pro-rated compensation in line with standard non-employee director arrangements.
  • As part of these changes, Grace Pugh Whiteford has been reclassified as a Class I director, with her term now expiring at the 2028 annual meeting, to ensure board class balance as required by the company’s governing documents.

Details for Investors:

On March 6, 2026, the Board of Directors (the “Board”) of Phillips 66, a leading energy manufacturing and logistics company, announced the appointment of two new directors: Dr. Meyers and Mr. Ungerleider. The company made clear that there were no arrangements or understandings with any persons pursuant to which these individuals were appointed, and neither has any material interest in transactions that would require disclosure under Item 404(a) of Regulation S-K.

The new directors will receive a pro-rated compensation package in accordance with the standard compensatory arrangements for non-employee directors. These arrangements are detailed under “Director Compensation” in the company’s definitive proxy statement (Schedule 14A) filed with the SEC on April 8, 2025, as may be amended. This ensures transparency and alignment with shareholder interests regarding director pay.

Board Structure Changes:
In conjunction with the appointments, and for the purpose of maintaining an even distribution of board members across its three classes, the Board has reclassified current director Grace Pugh Whiteford as a Class I director. As a result, her term will now expire at the 2028 annual meeting of stockholders. This action is solely to comply with the company’s governing documents and does not reflect any concerns about her performance.


Potential Shareholder Impact / Price Sensitivity:

  • The appointment of new board members, especially those with potentially significant industry experience or strategic vision, can be viewed positively by investors as it may signal fresh perspectives and renewed focus on governance and oversight.
  • The reclassification of director terms is a technical adjustment for compliance and does not reflect any operational or strategic shifts at Phillips 66.
  • No immediate price-sensitive transactions, mergers, or strategic reviews have been announced in connection with these board changes. There are also no material interests or related-party transactions disclosed regarding the new appointments.

As always, investors are encouraged to review the company’s proxy statement and public filings for further details on director compensation and governance practices.


Background Information:

  • Company Name: Phillips 66
  • Industry: Petroleum Refining
  • State of Incorporation: Delaware
  • Business Address: 2331 CityWest Blvd., Houston, TX 77042
  • Trading Symbol: PSX (NYSE)

Conclusion:

While board refreshment and director appointments are important to ongoing corporate governance, the changes announced do not reflect any immediate operational or strategic shift for Phillips 66. There are no price-sensitive events such as mergers, acquisitions, or major restructuring associated with these announcements. The pro-rated compensation and the technical rebalancing of board classes are standard governance actions.


Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consult with their financial advisors before making any investment decisions. The information in this article is based solely on the company’s public SEC filings and may not include all material information available to the company or its directors.

View Phillips 66 Historical chart here



CAMP4 Therapeutics 2025 10-K Report: RNA-Targeting Therapeutics, RAP Platform, Pipeline, Partnerships, and Regulatory Overview

CAMP4 Therapeutics 2025 Annual Report: Key Investor Insights CAMP4 Therapeutics Releases 2025 Annual Report: Key Insights for Investors CAMP4 Therapeutics Corp. (NASDAQ: CAMP) has released its Annual Report on Form 10-K for the fiscal...

Entravision Communications Corporation 2025 Annual Report: Business Overview, Risk Factors, Cybersecurity, Financials, and Governance 42

Entravision Communications Corp 2025 10-K: Key Highlights and Investor Analysis Entravision Communications Corp 2025 10-K: Key Highlights and Investor Analysis Major Developments and Financial Highlights Divestiture of Entravision Global Partners (EGP): Entravision completed the...

Pasqal to Go Public via $2 Billion SPAC Merger with Bleichroeder Acquisition Corp II, Accelerating Neutral Atom Quantum Computing Commercialization 12

Pasqal to Go Public via \$2B SPAC Deal: Investor-Focused Deep Dive Pasqal to Go Public via \$2 Billion SPAC Deal with Bleichroeder Acquisition Corp II Key Highlights Pasqal, a global leader in neutral atom...

   Ad